GGrantIndex
← Leaderboards

Samuel I Stupp

Northwestern University

Google Scholar ↗PubMed ↗ORCID ↗
$23,436,187
Attributed
$28,759,238
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,759,238 · 11

By mechanism

R01$26,438,718 · 5
U54$998,476 · 1
R61$762,606 · 1
P50$464,478 · 1
PN1$72,795 · 1
P41$12,165 · 1

Top collaborators

Most similar at Northwestern University

Same institution · by research overlap

Others in their field

Top investigators on “Peptides”

Research focus

PeptidesDesignCellsRattusNanofiberIn VitroBaseNanoscaleScaffoldProteinsIn VivoTechnologySignal TransductionSiteBiomedical EngineeringBiologicalGrowth FactorMolecularRegenerative MedicineRepairedNatural RegenerationPropertyInjuryTissues

Grant awards (48)

Development of a multi-modal targeted nanotherapeutic to prevent restenosis in an atherosclerotic environment$635,074
R01 · FY2025 · HL
Development of a multi-modal targeted nanotherapeutic to prevent restenosis in an atherosclerotic environment$618,998
R01 · FY2024 · HL
VEGF-Mimetic Supramolecular Nanoparticles for Treating Spinocerebellar Ataxia Type 1$401,334
R61 · FY2024 · NS
Development of a multi-modal targeted nanotherapeutic to prevent restenosis in an atherosclerotic environment$626,054
R01 · FY2023 · HL
VEGF-Mimetic Supramolecular Nanoparticles for Treating Spinocerebellar Ataxia Type 1$361,272
R61 · FY2023 · NS
Development of a multi-modal targeted nanotherapeutic to prevent restenosis in an atherosclerotic environment$664,358
R01 · FY2022 · HL
Supramolecular nanofibers for recombinant growth factor-free spine fusion$551,958
R01 · FY2022 · AR · contact PI
Supramolecular nanofibers for recombinant growth factor-free spine fusion$622,441
R01 · FY2021 · AR · contact PI
Supramolecular nanofibers for recombinant growth factor-free spine fusion$631,993
R01 · FY2020 · AR · contact PI
Supramolecular nanofibers for recombinant growth factor-free spine fusion$636,272
R01 · FY2019 · AR · contact PI
Supramolecular nanofibers for recombinant growth factor-free spine fusion$650,772
R01 · FY2018 · AR · contact PI
Novel Vehicles for Targeted Cardiovascular Repair$1,102,604
R01 · FY2016 · HL
Novel Vehicles for Targeted Cardiovascular Repair$1,103,789
R01 · FY2015 · HL
Bioactive Scaffolds for Regeneration in Spinal Cord Injury$663,372
R01 · FY2015 · EB · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$492,386
R01 · FY2015 · DE · contact PI
Novel Vehicles for Targeted Cardiovascular Repair$1,070,603
R01 · FY2014 · HL
Bioactive Scaffolds for Regeneration in Spinal Cord Injury$591,227
R01 · FY2014 · EB · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$504,450
R01 · FY2014 · DE · contact PI
Bioactive Scaffolds for Regeneration in Spinal Cord Injury$67,924
R01 · FY2014 · EB · contact PI
Novel Vehicles for Targeted Cardiovascular Repair$999,212
R01 · FY2013 · HL
Bioactive Scaffolds for Regeneration in Spinal Cord Injury$579,404
R01 · FY2013 · EB · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$495,881
R01 · FY2013 · DE · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$276,733
R01 · FY2013 · DE · contact PI
2013 Chemistry of Supramolecules and Assemblies Gordon Research Conference and Go$10,000
R13 · FY2013 · EB · contact PI
Bioactive Scaffolds for Regeneration in Spinal Cord Injury$618,468
R01 · FY2012 · EB · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$528,764
R01 · FY2012 · DE · contact PI
Bioactive Scaffolds for Regeneration in Spinal Cord Injury$621,433
R01 · FY2011 · EB · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$552,899
R01 · FY2011 · DE · contact PI
MOLECULAR PACKING AND ORIENTATION OF SELF-ASSEMBLED PEPTIDE AMPHIPHILE SYSTEM$12,165
P41 · FY2011 · RR · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$602,628
R01 · FY2009 · DE · contact PI
Multifunctional Nanostructures for Therapeutic Targeting of Breast cancer$594,551
U54 · FY2009 · CA · contact PI
Regenerative Scaffold Technologies for CNS and Diabetes$1,565,547
R01 · FY2008 · EB · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$593,644
R01 · FY2008 · DE · contact PI
Multifunctional Nanostructures for Therapeutic Targeting of Breast cancer$403,925
U54 · FY2008 · CA · contact PI
Matrix Synthesis and Biomaterials Core$124,084
P50 · FY2008 · NS · contact PI
Regenerative Scaffold Technologies for CNS and Diabetes$1,530,706
R01 · FY2007 · EB · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$582,655
R01 · FY2007 · DE · contact PI
Matrix Synthesis and Biomaterials Core$127,111
P50 · FY2007 · NS · contact PI
Regenerative Scaffold Technologies for CNS and Diabetes$7,888
R01 · FY2007 · EB · contact PI
Regenerative Scaffold Technologies for CNS and Diabetes$1,489,409
R01 · FY2006 · EB · contact PI
Nanotechnology Strategies for Growth of Bones and Teeth$581,815
R01 · FY2006 · DE · contact PI
Nanofibrils and Embryonic Stem Cells: Differentiation of Insulin-Secreting Cells$119,541
R01 · FY2006 · EB · contact PI
Matrix Synthesis and Biomaterials Core$101,510
P50 · FY2006 · NS · contact PI
Regenerative Scaffold Technologies for CNS and Diabetes$1,485,127
R01 · FY2005 · EB
Nanotechnology Strategies for Growth of Bones and Teeth$637,472
R01 · FY2005 · DE
Matrix Synthesis and Biomaterials Core$111,773
P50 · FY2005 · NS
Regenerative Scaffold Technologies for CNS and Diabetes$1,335,217
R01 · FY2004 · EB
Nanomachinery of the Cytoskeleton (RMI)$72,795
PN1 · FY2004 · EY